| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;36:929.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Clinical Physiology (J.O.T., J.J.H., O.T.R.), the Department of Medicine (H.L., J.S.A.V.), the Department of Radiology (A.H.) Turku University Hospital; the MCA Research Laboratory (M.A.); and Turku PET-Centre (O.T.R.), University of Turku, Finland.
Correspondence to Dr Olli T. Raitakari, Turku PET-Centre, Turku University, Kiinamyllynkatu 4-8, FIN-20520, Turku, Finland. E-mail olli.raitakari{at}utu.fi
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, borderline oxidized LDL intima-media thickness
| Introduction |
|---|
|
|
|---|
Therefore, to study the early cardiovascular and metabolic changes in BHT, we compared 2 matched groups of asymptomatic young men that were prospectively selected according to previously measured blood pressure values over 2 to 3 years. Our results suggest that the early pathophysiologic events related to blood pressure elevation include increased peripheral artery wall thickness and LDL oxidation (ox-LDL), and that these changes seem to occur before significant adaptations are seen in cardiac structure.
| Methods |
|---|
|
|
|---|
1 year apart. The group with BHT
included men with blood pressure values defined as high normal
(systolic blood pressure 130 to 140 mm Hg or
diastolic blood pressure 85 to 89 mm Hg in all
previous measurements).8 The control group included men
with normal blood pressure (<130/85 mm Hg) in each measurement.
The study protocol was performed on 16 men with BHT and 22 controls
matched for age, body mass index, and serum cholesterol
concentration. All men gave their written informed consent. The study
was conducted according to the guidelines of the Declaration of
Helsinki, and the study protocol had been approved by the Ethics
Committee of Turku University and Turku University Central
Hospital.
Ultrasound Imaging
All measurements were performed with Acuson 128XP/10 (Acuson
Inc) ultrasonography, with the use of 7 MHz scanning frequency
linear-array transducer in peripheral artery imaging
(carotid and brachial arteries) and 2.5/3.5 MHz scanning frequency
phased-array transducer in echocardiographic
imaging.
Intima-Media Thickness
Both sides of the common carotid artery diameter were scanned,
and the images of the distal 10 mm of the common carotid artery
(far wall) were recorded. Ultrasound scans were recorded on
videotape for later, off-line analysis. Several
end-diastolic frames were selected and analyzed
with a custom-made software program to determine mean carotid IMT. The
interobserver and intraobserver coefficient of variation of carotid IMT
measurements were 5.2±4.1% and 4.0±3.2%, respectively. Brachial
artery far-wall IMT was measured in end-diastole in at
least 3 different locations and in 3 different cardiac cycles. The mean
of these 9 measurements was used as the brachial IMT.
Echocardiography
The men were examined in a left lateral decubitus position. Left
ventricular dimensions were obtained from M-mode tracings.
Left ventricular mass (LVM) was calculated according to the
Penn convention.9 LVM index was calculated by dividing LVM
by body surface area. Septal to posterior wall ratio and relative wall
thickness (2xposterior wall thickness ·
end-diastolic dimension-1) were
calculated as measures of left ventricular
geometry.10 Left ventricular (LV)
systolic function was assessed by calculating the ejection
fraction as (LV diastolic volume-LV systolic
volume)/LV diastolic volume. LV diastolic
function was assessed by calculating the ratio of the early and late
mitral flow peak velocities (E/A-ratio) measured from the mitral flow
velocity tracings.
Endothelial Function
Brachial artery scans were obtained at rest, during reactive
hyperemia (with increased flow causing flow-mediated,
endothelium-dependent dilatation), and after sublingual
nitrate (causing endothelium-independent
vasodilation).6 The brachial artery was scanned in
longitudinal section
5 to 15 cm above the elbow. Increased flow was
induced by inflation of a pneumatic tourniquet placed around the
forearm to a pressure of 250 mm Hg for 4.5 minutes and then
released. A second scan was taken continuously for 30 seconds before
and 90 seconds after cuff deflation. Thereafter, 10 to 15 minutes was
allowed for vessel recovery, after which sublingual
nitroglycerin (isosorbide dinitrate spray 2.5 mg) was
administered, and the last scan was acquired 3 to 4 minutes later. For
the reactive hyperemia scan, diameter measurements were taken
60 seconds after cuff deflation. The vessel diameter in scans after
reactive hyperemia and nitroglycerin
administration was expressed as the percentage relative to the average
diameter of the artery in the resting scan (100%). The interobserver
variation for measurements of flow-mediated dilatation in our
laboratory was 0.63±0.45% (range 0.14% to 1.63%; CV, 8.6±6.4%)
and the intraobserver variation of 2 consecutive (6 months apart)
measurements was 0.48±0.43% (range 0.07% to 1.34%; CV,
6.2±4.4%).11
Ambulatory Blood Pressure Measurements
Ambulatory blood pressure was monitored with an auscultatory
method (Novacor Diasys). The device was installed in the left arm in
the morning, and blood pressure was verified against a mercury
sphygmomanometer both when installing and taking off the automated
device. The ambulatory blood pressure was recorded at 20-minute
intervals during daytime and at 60-minute intervals during
night-time.
Ox-LDL, Serum Lipoproteins, and Insulin
Venous blood was collected after an overnight fast. Serum total
cholesterol, HDL cholesterol and
triglyceride concentrations were measured with the use of
standard enzymatic methods (Boehringer Mannheim GmbH) with a
fully automated analyzer (Hitachi 704, Hitachi Ltd). HDL
cholesterol concentration was measured after polyethylene
glycol precipitation. LDL cholesterol concentration was
calculated using Friedewalds equation. Serum insulin concentration
was measured by radioimmunoassay kit (Pharmacia).
Conjugated dienes of LDL as markers of ox-LDL were measured by determining the level of LDL diene conjugation.12 In brief, serum LDL cholesterol was isolated by precipitation with buffered heparin. The amount of peroxidized lipids in samples was determined by degree of conjugated diene double bonds. Lipids were extracted from the samples and analyzed spectrophotometrically at 234 nm.
Statistical Methods
Results are expressed as mean±standard deviation. Distribution
of serum triglyceride and insulin values were skewed and
therefore included as their logarithms in the analyses.
Comparisons between the study groups were conducted by use of the
Students t test and ANCOVA (to control for the differences
in triglyceride and insulin values between the groups).
Univariate associations were studied by calculating
Pearsons correlation coefficients; multivariate
modeling was performed with stepwise multivariate
linear regression analysis with P<0.15 as model
entry criteria.
| Results |
|---|
|
|
|---|
|
The findings of the echocardiographic examination are shown in Table 2. LVM was similar between the study groups (P=0.55), but men with BHT tended to have increased relative wall thickness (P=0.07), decreased septal to posterior wall ratio (P=0.04), and decreased E/A-ratio (P=0.09).
|
IMT and Ox-LDL
Luminal diameters of carotid (5.8±0.5 versus 5.7±0.4 mm,
P=0.46) and brachial (4.6±0.4 versus 4.6±0.6 mm,
P=0.93) arteries were similar in the controls and in men
with BHT, respectively. Carotid IMT was 0.58±0.06 mm in the
control group and 0.75±0.07 mm in the BHT group
(P<0.001; Figure 1). Brachial
IMT was 0.45±0.05 mm in controls and 0.57±0.07 mm in men
with BHT (P<0.001; Figure 1). There was a
significant correlation between carotid IMT and brachial IMT
(r=0.60, P<0.001). Ox-LDL was 29±9 mmol/L
in the control group and 47±17 mmol/L in the BHT group
(P<0.001; Figure 2). The
differences in carotid and brachial IMTs and in ox-LDL between the
study groups remained highly significant (all P<0.05) after
adjustment for triglyceride and insulin levels.
|
|
Carotid artery IMT correlated with 24-hour systolic blood pressure (r=0.59, P<0.001) (Figure 3), 24-hour diastolic blood pressure (r=0.50, P=0.001), ox-LDL (r=0.49, P=0.002) (Figure 3), systolic blood pressure (r=0.50, P=0.001), diastolic blood pressure (r=0.46, P=0.004), triglycerides (r=0.59, P<0.001) and insulin (r=0.39, P=0.016), and tended to correlate with pulse pressure (r=0.27, P=0.11). Brachial artery IMT correlated with 24-hour systolic blood pressure (r=0.51, P=0.001), 24-hour diastolic blood pressure (r=0.44, P=0.006), ox-LDL (r=0.33, P=0.042), systolic blood pressure (r=0.44, P=0.006), and diastolic blood pressure (r=0.43, P=0.007).
|
In stepwise multivariate linear regression analyses, the predictors of carotid IMT were 24-hour systolic blood pressure (P<0.001) and ox-LDL (P=0.10), which were both directly associated with carotid IMT. These 2 variables explained 40% of the variance in carotid IMT. The only predictor of brachial IMT was 24-hour systolic blood pressure (P=0.001), which explained 26% of the variance of brachial IMT.
Endothelial Function
Flow-mediated dilatation did not differ between the groups
(3.82±3.73% versus 3.73±4.97%, P=0.95). Nitrate-mediated
dilatation was similar in both groups (14.5±7.0% versus
15.1±6.9%, P=0.81). Flow-mediated dilatation correlated
significantly with total cholesterol concentration
(r=0.42, P=0.009), LDL
cholesterol concentration (r=0.49,
P=0.002), and brachial artery baseline diameter
(r=0.48, P=0.002), but not with 24-hour
systolic (r=0.13, P=0.42) or
diastolic (r=0.13, P=0.43) blood
pressure.
| Discussion |
|---|
|
|
|---|
Oxidation of LDL is an important early event in the pathogenesis of atherosclerosis. Ox-LDL has been implicated in the increased formation of fatty streaks in the arterial intima, which represent the earliest form of atherosclerotic lesion.13 Previous studies have suggested that hypertension may be related to increased ox-LDL by showing either increased in vitro oxidizability of LDL3 or elevated titers of autoantibodies against ox-LDL in subjects with essential hypertension.2 Our study extends these observations and provides the first direct evidence of enhanced ox-LDL in men with BHT. In contrast to our findings, Wu et al14 recently described decreased titers of autoantibodies against ox-LDL in subjects with BHT. This apparent discrepancy might be explained by the possibility that in certain circumstances, decreased titers of autoantibodies against oxidatively modified LDL may not reflect decreased lipoprotein oxidation, but instead indicate either altered immunoresponse to ox-LDL or increased consumption of autoantibodies due to binding to early atherosclerotic lesions.14
Some insights on the mechanisms by which blood pressure elevation might increase ox-LDL have been gained by experimental studies suggesting the importance of pressure changes on the arterial wall in the development of atherosclerosis and lipoprotein oxidation. Meyer et al15 induced luminal pressures on rabbit aorta in vitro and observed that this stretching increased the uptake of LDL into the arterial wall. More recently, Inoue et al16 observed that mechanical stretching of cultured smooth muscle cells enhances ox-LDL and superoxide production in the exposed cells.16 Thus, the combination of increased influx of LDL into the arterial wall and increased oxidative stress may offer a mechanistic explanation of how elevated blood pressure enhances the development of atherosclerosis and ox-LDL.
The results of the present study show that in prehypertension, structural changes appear first in the peripheral arteries before significant adaptation is seen in cardiac size. Although we did not find any increase in the LVM in men with BHT, our data nevertheless revealed subtle changes in indices of cardiac function and geometry, such as increased ejection fraction and relative wall thickness, and altered diastolic filling patterns. If the number of men had been greater, more of these indices might have been significantly different between the study groups. These early adaptive cardiac changes may precede the development of overt left ventricular hypertrophy.17 The change in LV geometry in BHT may also partly explain increased ox-LDL, since myocardial stretch may be associated with up-regulation of endothelial ox-LDL receptor.18
Men with BHT had similar brachial artery endothelial function compared with controls. Hypertension appears to have little effect on flow-mediated conduit artery capacity,19 although most studies,20 21 but not all,22 23 have suggested impaired endothelium-dependent vasodilation in the resistance vessels of subjects with elevated blood pressure. These observations may suggest difference in endothelial susceptibility between conduit and resistance vessels to the effects of hypertension. In our study, endothelial function was, nevertheless, closely related with serum LDL cholesterol, demonstrating the importance of standard lipid risk factors in determining endothelial function in young men.
The ultrasound method for IMT does not allow for differentiation between intimal thickening due to atherosclerotic process or medial hypertrophy (smooth muscle growth) due to pressure effects. Therefore, it is not clear whether the increase in IMT in men with BHT represents the former or the latter, although previous observations suggest that IMT may be more closely related to intimal atherosclerotic process.24 Increased IMT correlates significantly with traditional vascular risk factors,6 predicts the likelihood of cardiovascular events in population groups,25 26 and is related to the severity and extent of coronary artery disease.27
We measured ox-LDL with the use of an assay that measures LDL diene conjugation based on spectrophotometric analysis of LDL lipids. Therefore, it is possible that lipophilic substances of plasma that are transported within the LDL fraction and absorb light at 234 nm may potentially interfere with this assay. We have recently shown in healthy volunteers, however, a close correlation between LDL baseline diene conjugation and the in vivo ox-LDL measured as the titer of serum autoantibodies against oxidized LDL particles.12
These data provide evidence of increased in vivo ox-LDL and subclinical atherosclerosis in men with BHT. Our results are consistent with the idea that enhanced ox-LDL may be one of the pathophysiological events related to development of atherosclerosis in hypertension.
| Acknowledgments |
|---|
Received February 15, 2000; first decision April 11, 2000; accepted June 26, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. M. Egan, S. D. Nesbitt, and S. Julius Review: Prehypertension: should we be treating with pharmacologic therapy? Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 305 - 314. [Abstract] [PDF] |
||||
![]() |
J. Aittokallio, O. Polo, J. Hiissa, A. Virkki, J. Toikka, O. Raitakari, T. Saaresranta, and T. Aittokallio Overnight variability in transcutaneous carbon dioxide predicts vascular impairment in women Exp Physiol, July 1, 2008; 93(7): 880 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mattsson, T. Ronnemaa, M. Juonala, J. S.A. Viikari, E. Jokinen, N. Hutri-Kahonen, M. Kahonen, T. Laitinen, and O. T. Raitakari Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study Eur. Heart J., March 2, 2008; 29(6): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Femia, M. Kozakova, M. Nannipieri, C. Gonzales-Villalpando, M. P. Stern, S. M. Haffner, and E. Ferrannini Carotid Intima-Media Thickness in Confirmed Prehypertensive Subjects: Predictors and Progression Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2244 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Keltikangas-Jarvinen, T. Hintsa, M. Kivimaki, S. Puttonen, M. Juonala, J. S.A. Viikari, and O. T. Raitakari Type A Eagerness-Energy Across Developmental Periods Predicts Adulthood Carotid Intima-Media Thickness: The Cardiovascular Risk in Young Finns Study Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1638 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Drukteinis, M. J. Roman, R. R. Fabsitz, E. T. Lee, L. G. Best, M. Russell, and R. B. Devereux Cardiac and Systemic Hemodynamic Characteristics of Hypertension and Prehypertension in Adolescents and Young Adults: The Strong Heart Study Circulation, January 16, 2007; 115(2): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Svetkey Management of Prehypertension Hypertension, June 1, 2005; 45(6): 1056 - 1061. [Full Text] [PDF] |
||||
![]() |
M. J. Jarvisalo, M. Raitakari, J. O. Toikka, A. Putto-Laurila, R. Rontu, S. Laine, T. Lehtimaki, T. Ronnemaa, J. Viikari, and O. T. Raitakari Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes Circulation, April 13, 2004; 109(14): 1750 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raitakari, T. Ilvonen, M. Ahotupa, T. Lehtimaki, A. Harmoinen, P. Suominen, J. Elo, J. Hartiala, and O. T. Raitakari Weight Reduction With Very-Low-Caloric Diet and Endothelial Function in Overweight Adults: Role of Plasma Glucose Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 124 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Paiva, J. Laakso, H. Laine, R. Laaksonen, J. Knuuti, and O. T. Raitakari Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1241 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Cheng, D. P. Mikhailidis, G. Hamilton, and A. M. Seifalian A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors Cardiovasc Res, June 1, 2002; 54(3): 528 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jartti, T. Ronnemaa, J. Kaprio, M.J. Jarvisalo, J.O. Toikka, J. Marniemi, N. Hammar, L. Alfredsson, M. Saraste, J. Hartiala, et al. Population-Based Twin Study of the Effects of Migration From Finland to Sweden on Endothelial Function and Intima-Media Thickness Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 832 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Jarvisalo, A. Putto-Laurila, L. Jartti, T. Lehtimaki, T. Solakivi, T. Ronnemaa, and O. T. Raitakari Carotid Artery Intima-Media Thickness in Children With Type 1 Diabetes Diabetes, February 1, 2002; 51(2): 493 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Jarvisalo, L. Jartti, K. Nanto-Salonen, K. Irjala, T. Ronnemaa, J. J. Hartiala, D. S. Celermajer, and O. T. Raitakari Increased Aortic Intima-Media Thickness: A Marker of Preclinical Atherosclerosis in High-Risk Children Circulation, December 11, 2001; 104(24): 2943 - 2947. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |